142 related articles for article (PubMed ID: 38102655)
1. Multiparametric bone MRI targeting aides lesion selection for CT-guided sclerotic bone biopsies in metastatic castrate resistant prostate cancer.
Donners R; Figueiredo I; Westaby D; Koh DM; Tunariu N; Carreira S; de Bono JS; Fotiadis N
Cancer Imaging; 2023 Dec; 23(1):121. PubMed ID: 38102655
[TBL] [Abstract][Full Text] [Related]
2. Multiparametric bone MRI can improve CT-guided bone biopsy target selection in cancer patients and increase diagnostic yield and feasibility of next-generation tumour sequencing.
Donners R; Figueiredo I; Tunariu N; Blackledge M; Koh DM; de la Maza MLDF; Chandran K; de Bono JS; Fotiadis N
Eur Radiol; 2022 Jul; 32(7):4647-4656. PubMed ID: 35092476
[TBL] [Abstract][Full Text] [Related]
3. Optimising CT-guided biopsies of sclerotic bone lesions in cancer patients.
Donners R; Fotiadis N; Figueiredo I; Blackledge M; Westaby D; Guo C; Fenor de la Maza MLD; Koh DM; Tunariu N
Eur Radiol; 2022 Oct; 32(10):6820-6829. PubMed ID: 35881184
[TBL] [Abstract][Full Text] [Related]
4.
van Steenbergen TRF; Smits M; Scheenen TWJ; van Oort IM; Nagarajah J; Rovers MM; Mehra N; Fütterer JJ
Cardiovasc Intervent Radiol; 2020 Jan; 43(1):147-154. PubMed ID: 31444628
[TBL] [Abstract][Full Text] [Related]
5. Repeatability of quantitative individual lesion and total disease multiparametric whole-body MRI measurements in prostate cancer bone metastases.
Donners R; Candito A; Blackledge M; Rata M; Messiou C; Koh DM; Tunariu N
Br J Radiol; 2023 Nov; 96(1151):20230378. PubMed ID: 37660399
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric Magnetic Resonance Imaging of Prostate Cancer Bone Disease: Correlation With Bone Biopsy Histological and Molecular Features.
Perez-Lopez R; Nava Rodrigues D; Figueiredo I; Mateo J; Collins DJ; Koh DM; de Bono JS; Tunariu N
Invest Radiol; 2018 Feb; 53(2):96-102. PubMed ID: 28906339
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow biopsy: RNA isolation with expression profiling in men with metastatic castration-resistant prostate cancer--factors affecting diagnostic success.
Spritzer CE; Afonso PD; Vinson EN; Turnbull JD; Morris KK; Foye A; Madden JF; Roy Choudhury K; Febbo PG; George DJ
Radiology; 2013 Dec; 269(3):816-23. PubMed ID: 23925271
[TBL] [Abstract][Full Text] [Related]
8. CT-Guided Bone Biopsies in Metastatic Castration-Resistant Prostate Cancer: Factors Predictive of Maximum Tumor Yield.
Holmes MG; Foss E; Joseph G; Foye A; Beckett B; Motamedi D; Youngren J; Thomas GV; Huang J; Aggarwal R; Alumkal JJ; Beer TM; Small EJ; Link TM
J Vasc Interv Radiol; 2017 Aug; 28(8):1073-1081.e1. PubMed ID: 28549709
[TBL] [Abstract][Full Text] [Related]
9. Inter- and Intra-Patient Repeatability of Radiomic Features from Multiparametric Whole-Body MRI in Patients with Metastatic Prostate Cancer.
Donners R; Candito A; Rata M; Sharp A; Messiou C; Koh DM; Tunariu N; Blackledge MD
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730599
[TBL] [Abstract][Full Text] [Related]
10. The value of baseline 18F-sodium fluoride and 18F-choline PET activity for identifying responders to radium-223 treatment in castration-resistant prostate cancer bone metastases.
Donners R; Tunariu N; Tovey H; Hall E; Chua S; Cook G; Du Y; Blackledge MD; Parker CC; Koh DM
Eur Radiol; 2024 Feb; 34(2):1146-1154. PubMed ID: 37615760
[TBL] [Abstract][Full Text] [Related]
11. Imaging, procedural and clinical variables associated with tumor yield on bone biopsy in metastatic castration-resistant prostate cancer.
McKay RR; Zukotynski KA; Werner L; Voznesensky O; Wu JS; Smith SE; Jiang Z; Melnick K; Yuan X; Kantoff PW; Montgomery B; Balk SP; Taplin ME
Prostate Cancer Prostatic Dis; 2014 Dec; 17(4):325-31. PubMed ID: 25091040
[TBL] [Abstract][Full Text] [Related]
12. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
Piert M; Montgomery J; Kunju LP; Siddiqui J; Rogers V; Rajendiran T; Johnson TD; Shao X; Davenport MS
J Nucl Med; 2016 Jul; 57(7):1065-70. PubMed ID: 26985061
[TBL] [Abstract][Full Text] [Related]
13. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
14. Whole-body MRI including diffusion-weighted imaging (DWI) for patients with recurring prostate cancer: technical feasibility and assessment of lesion conspicuity in DWI.
Eiber M; Holzapfel K; Ganter C; Epple K; Metz S; Geinitz H; Kübler H; Gaa J; Rummeny EJ; Beer AJ
J Magn Reson Imaging; 2011 May; 33(5):1160-70. PubMed ID: 21509875
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
16. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
17. 4D perfusion CT of prostate cancer for image-guided radiotherapy planning: A proof of concept study.
Beer L; Polanec SH; Baltzer PAT; Schatzl G; Georg D; Schestak C; Dutschke A; Herrmann H; Mazal P; Brendel AK; Shariat SF; Ringl H; Helbich TH; Apfaltrer P
PLoS One; 2019; 14(12):e0225673. PubMed ID: 31856177
[TBL] [Abstract][Full Text] [Related]
18. Association of quantitative magnetic resonance imaging parameters with histological findings from MRI/ultrasound fusion prostate biopsy.
Dianat SS; Carter HB; Schaeffer EM; Hamper UM; Epstein JI; Macura KJ
Can J Urol; 2015 Oct; 22(5):7965-72. PubMed ID: 26432966
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study.
Brown LC; Ahmed HU; Faria R; El-Shater Bosaily A; Gabe R; Kaplan RS; Parmar M; Collaco-Moraes Y; Ward K; Hindley RG; Freeman A; Kirkham A; Oldroyd R; Parker C; Bott S; Burns-Cox N; Dudderidge T; Ghei M; Henderson A; Persad R; Rosario DJ; Shergill I; Winkler M; Soares M; Spackman E; Sculpher M; Emberton M
Health Technol Assess; 2018 Jul; 22(39):1-176. PubMed ID: 30040065
[TBL] [Abstract][Full Text] [Related]
20. Multiparametric Whole-body MRI with Diffusion-weighted Imaging and ADC Mapping for the Identification of Visceral and Osseous Metastases From Solid Tumors.
Jacobs MA; Macura KJ; Zaheer A; Antonarakis ES; Stearns V; Wolff AC; Feiweier T; Kamel IR; Wahl RL; Pan L
Acad Radiol; 2018 Nov; 25(11):1405-1414. PubMed ID: 29627288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
